Objectives
Individuals with rheumatoid arthritis (RA) are at a greater risk for cardiovascular disease (CVD). Vitamin D deficiency is a potential risk factor for CVD and metabolic syndrome. Since patients with RA have a high prevalence of vitamin D deficiency, we investigated the association of vitamin D levels with cardiometabolic risk factors in a cohort of RA patients with no prior history of CVD.
Methods
Serum 25(OH)D levels were measured among RA patients enrolled in a cohort study of subclinical CVD. The cross-sectional associations of 25(OH)D level with traditional CVD risk factors, such as insulin resistance [estimated using the Homeostatic Model Assessment (HOMA)], adiopokines, markers of systemic inflammation and endothelial activation were explored, adjusting for pertinent sociodemographic, lifestyle, and RA characteristics.
Results
Among 179 RA patients, 73 (41%) had a 25(OH)D level <30ng/mL. Only 23 patients (13%) had a 25(OH)D level ≥45ng/mL. After adjusting for demographics and BMI, 25(OH)D remained significantly associated with HDL and inversely associated with HOMA-IR, fibrinogen, E-selectin, and s-ICAM. Significant associations with HDL, E-selectin, and s-ICAM were maintained after adjusting for DAS28 and autoantibody status. These associations were similar between groups subdivided by gender, ethnicity, body mass index, DAS28 level and autoantibody status.
Conclusions
These data suggest that vitamin D deficiency is common in RA and may be independently associated with several cardiometabolic intermediates in this population.